
Why Trump’s Obesity Drug ‘Deal’ Will Help Big Pharma Most Of All
With the market for GLP-1s already exploding, Americans might be best served by a government that focuses on promoting competition to drive down prices.
You may also like
By mfnnews
search
categories
Archives
navigation
Recent posts
- The families behind our veterans deserve more than once-a-year thanks November 27, 2025
- 7 Filipino human trafficking victims repatriated — BI November 27, 2025
- NBA: Zach Edey-led Grizzlies outlast Pelicans in overtime November 27, 2025
- NBA: De’Aaron Fox’s season-high 37 spark Spurs past Blazers November 27, 2025
- NBA: Brandon Ingram’s last-second hoop lifts Raptors over Pacers November 27, 2025
- NCAA: San Beda ousts LPU to book Final Four slot November 27, 2025
- NBA: Heat hold on for 6th straight win at Bucks’ expense November 27, 2025








Leave a Reply
You must be logged in to post a comment.